EP4-IN-1 is a potent prostanoid EP4 receptor inhibitor. EP4-IN-1 is extracted from patent WO2023025270 (example 1), and exhibits prospect in tumor immunity and anti-inflammatory analgesia research.
References:
[1]. Deng qi yuan,et al. Solid form of indole compound, preparation method therefor and use thereof. Patent WO2023025270A1.
















